Monteris Medical   Report issue

For profit Phase 1 Phase 2
Founded: Winnipeg Canada (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2017
NCT03022578
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Monteris Medical | Monteris Medical Corporation